Tongue Stimulation for Tinnitus
Last reviewed October 2026 · Based on 8 studies
Bottom line
Pairing sound with mild electrical stimulation of the tongue (the Lenire device) lowered tinnitus handicap scores in large trials, and the gains lasted up to 12 months in some settings. In people with moderate or worse tinnitus, 59% improved meaningfully with the combination versus 43% with sound alone. The trials we could check were run with the device maker and none used an inactive device, so the evidence is promising but limited.
What it helps with
- Reduces tinnitus handicap and distress — Benefit, evidence grade C (Limited). Several randomised trials and a 2026 meta-analysis show clear drops in handicap scores, but the later trials and a chart review are linked to the device maker, none used an inactive device, and the controlled comparison shows added benefit over sound alone only in moderate or worse tinnitus; downgraded for risk of bias.
- Relief lasts for months after treatment ends — Benefit, evidence grade C (Limited). Two randomised trials followed people for 12 months after treatment, but without an inactive comparison and with maker-linked authors on the later trial; downgraded for risk of bias.
What it is
A wearable treatment that plays sound through headphones while a small electrode delivers mild electrical pulses to the tongue [1]. It is called bimodal because it combines two senses, hearing and touch. In the trials it was used for up to one hour a day, in two 30-minute sessions, for 12 weeks [2]. The Lenire device received US FDA De Novo approval for tinnitus [2].
How it might work
Animal research suggests that sound paired with electrical stimulation of touch pathways can drive plasticity (rewiring) in the auditory brain [1]. This mechanism is proposed, not proven in people.
What the research says
Large randomised trials. In an exploratory, double-blinded trial of 326 adults with chronic tinnitus, three different stimulation settings each reduced tinnitus handicap over 12 weeks (effect sizes of -0.87 to -0.92 on the Tinnitus Handicap Inventory and -0.77 to -0.87 on the Tinnitus Functional Index), and for specific settings the improvement continued for 12 months after treatment ended [1]. A second randomised, double-blind trial found that two settings both reduced symptoms, with further improvement when the settings were changed after 6 weeks, effects sustained up to 12 months, and 83.8% of people using the device as directed [3]. Tongue stimulation with plain pure tones and no background noise was enough [3].
Sound alone versus sound plus tongue stimulation. In a trial of 112 adults each person had 6 weeks of sound only, then 6 weeks of sound with tongue stimulation. Among people with moderate or worse tinnitus, 58.6% improved by more than 7 points on the handicap inventory with the combination, against 43.2% with sound alone [2]. On the Tinnitus Functional Index, 45.5% improved by more than 13 points versus 29.6% [2]. In the full group including milder tinnitus the difference was not seen [2]. At the end, 62.9% of participants said they had benefited and 88.6% would recommend it [2].
Everyday clinics. In a chart review of 212 patients from one US clinic, 91.5% improved by more than 7 points, by 27.8 points on average [4]. In another review of 140 patients, 81.8% of those with moderate or worse tinnitus improved meaningfully (average drop of 23.8 points), while people with slight or mild tinnitus saw almost no change [5]. These reviews had no comparison group.
Pooled analysis. A 2026 meta-analysis of 26 randomised trials of brain-stimulation treatments for tinnitus found that bimodal stimulation (4 trials, 582 people) gave the most consistent and durable improvements, often 10 to 20 points on the handicap scales, lasting up to 12 months [6]. In the same review, magnetic and direct-current stimulation of the scalp did not reach a significant pooled effect [6].
Doses used in studies
Up to 60 minutes a day for 12 weeks, with settings adjusted after 6 weeks [3][2]. Real-world clinics prescribed up to 60 minutes daily with check-ups at 6 and 12 weeks [5]. This is what the studies used, not a recommendation.
Safety and interactions
Side effects. No device-related serious adverse events were reported in the trials [1][3][2]. Mild effects reported included jaw pain, tooth sensitivity, ear discomfort, dry mouth, headache and dizziness [3][2].
Who was excluded. The pivotal trial excluded people with pulsatile (heartbeat-like) tinnitus, Meniere's disease, jaw-joint disorders, burning mouth syndrome, psychosis or schizophrenia, conditions causing seizures or loss of consciousness, implanted electrical devices, pregnancy, oral piercings and a recent hearing-aid start [2]. Safety in these groups was not tested, so they should ask a doctor first.
Interactions and limits. No data on medicine interactions or on use beyond the 12-week courses were found.
Caveats and open questions
Authors of the second randomised trial, the controlled trial and one chart review are employees, consultants or shareholders of the device maker, or provide the treatment [3][2][4]. No independent trial turned up. The first large trials compared different active settings rather than an inactive device [1], and in the controlled comparison sound alone also helped 43% of people [2]. Benefit looks limited to moderate or worse tinnitus [2][5]. Cost and long-term use beyond a year were not studied in the papers reviewed.
References
- Bimodal neuromodulation combining sound and tongue stimulation reduces tinnitus symptoms in a large randomized clinical study.. Sci Transl Med, 2020.
- Combining sound with tongue stimulation for the treatment of tinnitus: a multi-site single-arm controlled pivotal trial.. Nat Commun, 2024.
- Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial.. Sci Rep, 2022.
- Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for tinnitus treatment in a clinical setting.. Commun Med (Lond), 2025.
- Bimodal Neuromodulation for Tinnitus in a Clinical Practice Setting: Clinically Significant Benefit for Patients With Moderate or Worse Symptoms.. Am J Audiol, 2026.
- Neuromodulation for Subjective Tinnitus: A Systematic Review and Meta-Analysis of Randomized Trials.. Laryngoscope, 2026.